؉ T cell responses, and may play a role in the immune dysregulation observed in HIV-1 infection. We characterized the Gag-specific IL-10 responses by CD8 
T he appearance of HIV-specific cytotoxic CD8
ϩ T lymphocytes (CTL) is associated with the drop in plasma virus levels during acute infection and the control of setpoint viremia during chronic infection (1, 2) . CTL are able to lyse infected cells before progeny virions are produced (3) , and therefore, have the potential to limit viral load and slow disease progression. Nevertheless, virus-specific CTL responses ultimately fail to prevent HIV disease progression (4) . The causes for the failure of cellular immunity to contain HIV infection remain poorly understood, but may be associated with the observed progressive functional defects in HIV-specific effector T cell function in chronic infection (4, 5) . Immune dysfunction in HIV infection has been shown to be associated with defects in cytokine production (6) , perforin expression (7) (8) (9) , alterations in phenotypic maturation (10, 11) , as well as decreased proliferative ability of virusspecific CD8 ϩ T cells (9, 12) . IL-10 is one of the key molecules involved with immunosuppression (reviewed in Ref. 13 ). The effect of IL-10 on CD8 ϩ T cell function is not fully understood (14 -17) , but may include regulatory properties (18) . Both CD4 ϩ and CD8 ϩ T cells have been shown to express high IL-10 levels in HIV infection (19, 20) . IL-10-producing HIV-specific CD25 ϩ CD4 ϩ regulatory T cells have previously been shown to suppress both CD4 ϩ and CD8 ϩ HIV-specific T cell function in vitro (21, 22) . In addition, a higher frequency of CD4 ϩ T cells producing IL-10 was observed in HIVinfected individuals with progressive or active HIV replication compared with nonprogressors (23) . To our knowledge, the relationship between IL-10 production by CD8 ϩ T cells and CD4 count, plasma HIV RNA, and HIV-specific function has not previously been examined. We describe a population of HIV-specific IL-10-positive T cells in HIV-1-infected volunteers from Uganda. The presence of these IL-10-positive CD8 ϩ T cells was associated with advanced HIV disease and correlated positively with plasma HIV RNA. Our data suggest that these IL10-positive CD8 ϩ T cells may have an important regulatory role in the immune dysfunction observed in HIV infection.
Materials and Methods

Study subjects and samples
HIV-1-positive volunteers (n ϭ 76) were recruited from the HIV clinic at the Joint Clinical Research Centre (JCRC; Kampala, Uganda). Sixty-one were antiretroviral (ARV) 3 naive and 15 volunteers had a complete virologic response on ARV therapy (Ͻ400 copies/ml). Demographic information was obtained at the time of enrollment and blood draw. Clinical characteristics including the prevalence of coinfections in this population were previously described (24, 25) . Exclusion criteria included age Ͻ18 years, pregnancy, active tuberculosis, Schistosoma mansoni coinfection, or moribund status. A summary of the patient clinical data is shown in Table I . Institutional Review Board approvals were obtained from the California Department of Health Services and the JCRC, and all study participants gave written informed consent. Absolute numbers of CD4 ϩ T cells were determined by BD TruCount (BD Biosciences) and the HIV-1 RNA level was determined from plasma using the Roche Amplicor 1.5 (Roche), as per manufacturer's recommendations, and the lower limit of detection was 400 copies/ml (26) . Isolation of PBMC was performed by Ficoll-Hypaque (Amersham Biosciences) density centrifugation. Cryopreserved PBMC and plasma were stored and shipped to the U.S. in liquid nitrogen.
sequence of the PP65 protein (BD Biosciences) was used to detect the human CMV (HCMV)-specific response (27, 28) 
Flow-based intracellular cytokine staining
Detection of Gag-specific IFN-␥ production was performed using PBMC (1 ϫ 10 6 ) incubated with Gag peptide pools for 2 h at 37°C in 5% CO 2 in the presence of costimulatory anti-CD49d and anti-CD28 (1 g/ml; BD Biosciences), followed by brefeldin A for 4 h as previously described (29, 30) . Detection of HIV-specific IL-10 production was performed using a similar protocol except Golgi stop (BD Pharmingen) was substituted for brefeldin A, and incubation time was extended to 12-14 h (25). PHA (10 g/ml; Sigma-Aldrich) and LPS (1 ng/ml; Sigma-Aldrich) were used as positive controls in the IFN-␥ and IL-10 assays, respectively. Media alone without Ag stimulation was used in negative controls. Cells were then stained with different combinations of the following Abs: IFN-␥ FITC, CD45RA FITC, IL-10 PE, CD45 RA PE, CCR7 PE CY7, CD3 PerCP Cy5.5, CD8 allophycocyanin Cy7, CD4 Pacific Blue (BD Pharmingen). A minimum of 30,000 CD3 ϩ cells/sample were acquired using a six-color flow cytometer (LSRII; BD Biosciences) and analysis was performed by FLOWJO software (Tree Star). Results were expressed as: the percentage of IFN-␥ or IL-10-positive CD8 ϩ T cells (percent positive ϭ percent Agspecific Ϫ percent negative control). Responses Ն0.1% and two times the background were considered positive. All volunteers demonstrated significant IFN-␥ and IL-10 production following PHA and LPS stimulation, respectively. Background expression was Ͻ0.05%.
CD107a/b degranulation assay
Degranulation assay was performed as previously described (31) . Cytotoxic CD8 ϩ T cell function has been shown to correlate directly with T cell degranulation which is a prerequisite process of perforin-granzyme-mediated lytic function (32) , and can be measured by increased expression of surface CD107 (31, 33) . Briefly, PBMC (0.5 ϫ 10 6 ) were incubated with 1 g/ml anti-CD49d and anti-CD28 (BD Biosciences), anti-CD107a and anti-CD107b FITC (CD107a/b; BD Biosciences), and Gag peptide pools, in a 0.2 ml final volume for 6 h. Staphylococcus enterotoxin B (1 g/ml; Sigma-Aldrich) and media alone were used as positive and negative controls, respectively. Cells were subsequently stained with anti-CD45 RA PE, anti-CCR7 PE CY7, anti-CD3 PerCP Cy5.5, and anti-CD8 allophycocyanin Cy7, CD4 Pacific Blue (BD Pharmingen). A minimum of 30,000 CD8 ϩ events/sample was acquired by flow cytometry. Percentages of CD3 ϩ CD8 ϩ T cells expressing CD107a/b were determined after subtraction of background activity using preset gating. Results were expressed as: the percentage of CD107a/b-positive CD8 ϩ T cells (percent positive ϭ percent Ag-specific Ϫ percent negative control). Responses Ն0.1% and two times the background were considered positive. All volunteers demonstrated significant CD107a/b expression following Staphylococcus enterotoxin B stimulation. Background expression was Ͻ0.1%.
S. mansoni ELISA
Serologic evidence for schistosomiasis was determined as previously described (25) from frozen plasma using anti-S. mansoni egg Ag ELISA (34) per manufacturer's instructions (IVD Research). We have previously demonstrated that S. mansoni coinfection was associated with increased frequency of IL-10-positive HIV-specific CD8 ϩ T cell responses (25) . Therefore, only individuals without serologic evidence of S. mansoni infection were evaluated in the current study to exclude schistosomiasis as a contributing factor in HIV-specific IL-10 production.
Cytokine ELISA
Plasma and PBMC (2 ϫ 10 6 /ml) cocultured with Gag peptides for 48 h were tested for the presence of IL-10 by ELISA (R&D Systems) according to the manufacturer's protocol. The lower limit of detection for IL-10 was 7.8 pg/ml per test sample. Results were expressed as the level of IL-10 in picograms per 100 l of plasma or supernatant. All samples with below detectable IL-10 levels were assigned a value of 7.8.
Statistical analysis
Groups were compared using the Mann-Whitney U test or the paired t test, and analysis was performed with PRISM software version 4.02 (GraphPad). The Spearman correlation coefficient was used to determine the correlation between two variables, and the linear least-square regression model was used in multivariate analysis. Statistical significance was defined as p Ͻ 0.05.
Results
Relationship between Gag-specific IL-10 expression by CD8 ϩ T cells and CD4 T cell count
An inverse correlation between CD4
ϩ T cell count and viral load has been reported (35) , and was also demonstrated in the current study participants (r ϭ Ϫ0.52; p Ͻ 0.0001, data not shown). However, the relationship between the CD4 ϩ T cell count and HIV-1-specific CD8
ϩ T cell IL-10 responses is unknown. We first determined the frequency of Gag-specific IL-10-positive CD8 ϩ T cells in 61 ARV naive HIV-1-infected volunteers (25) . Degranulation and IFN-␥ production by Gag-specific CD8 ϩ T cells were also determined concurrently. All volunteers demonstrated significant responses to at least one of the three markers examined. Representative plots of Gag-specific IL-10, degranulation, and IFN-␥-positive CD8 ϩ T cell responses from two volunteers are shown in Fig. 1 . Gag-specific IL-10-positive CD8 ϩ T cells were detected in 32 of 61 (52.4%) volunteers (Table II) . Interestingly, the IL-10-positive group had lower CD4 ϩ T cell count compared with the IL-10-negative group ( p ϭ 0.001). Gag-specific IL-10-positive CD8 ϩ T cells were detected in 23 of 31 (74.1%) volunteers with a CD4 ϩ T cell count Ͻ200 cells/mm 3 , and 9 of 30 (30%) volunteers with a CD4 ϩ T cell count Ͼ200 cells/mm 3 . The frequency of Gag-specific IL-10-positive CD8 ϩ T cells was significantly higher in volunteers with a CD4 ϩ T cell count Ͻ200 cells/mm 3 ( p ϭ 0.0004; Fig. 2 ).
To determine whether the presence of IL-10-positive HIV-specific CD8 ϩ T cells was associated with increased plasma IL-10 levels, we measured the plasma IL-10 levels and observed no significant differences between HIV-1-positive volunteers with or without Gag-specific IL-10-positive CD8 ϩ T cell responses ( p ϭ 0.28; data not shown). In addition, we were unable to detect IL-10 in the supernatant of PBMC following stimulation with Gag peptides (data not shown).
Relationship between Gag-specific IL-10 expression by CD8
ϩ T cells and plasma HIV RNA An inverse correlation between HIV-specific CTL responses and viral load has been reported (36 -39) . However, the lack of viral control in the presence of high frequencies of HIV-1-specific IFN-␥-positive T cell responses has also been described (33, 40 -42) . We found a significant positive correlation between the frequency of Gag-specific IL-10-positive CD8 ϩ T cells and plasma HIV RNA (r ϭ 0.43, p ϭ 0.0004; Fig. 3A ). This correlation remained significant in a multivariate least square regression analysis model after controlling for CD4 ϩ T cell count (R 2 ϭ 0.11; p ϭ 0.03, data not shown). In contrast, there was no correlation between the frequency of CD107a/b-positive CD8 ϩ T cells ( p ϭ 0.88; Fig. 3B ), or Gag-specific IFN-␥ ( p ϭ 0.89; Fig. 3C ), and plasma HIV RNA.
Early ARV therapy has been shown to reduce IL-10 production by CD4
ϩ T cells (23) . To determine the effect of ARV therapy on the frequency of Gag-specific IL-10-positive CD8
ϩ T cells, we measured Gag-specific CD8 ϩ T cell responses in 15 HIV-1-infected volunteers who achieved complete virologic response on ARV therapy (HIV RNA Ͻ400 copies/ml). There were no significant differences in age ( p ϭ 0.25) or CD4 T cell count ( p ϭ 0.28) between the ARV naive and ARV receiving volunteers (Table I) To determine whether the presence of IL-10-positive HIV-specific CD8
ϩ T cells was associated with altered responses against non-HIV Ags, we analyzed HCMV-specific responses in the same study population. PP65-specific CD8 ϩ T cell responses were detected in 54 of 61 study participants. No significant differences in the frequency of PP65-specific CD107a/b and IFN-␥-positive CD8 ϩ T cells were observed between volunteers with or without Gag-specific IL-10-positive HIV-specific CD8 ϩ T cell responses ( p ϭ 0.77, and p ϭ 0.33, respectively; data not shown). In addition, PP65-specific IL-10-positive CD8 ϩ T cell responses were not detected in most volunteers irrespective of the presence of Gagspecific IL-10-positive CD8 ϩ T cell responses.
Expression of surface memory markers by IL-10-positive Gagspecific CD8 ϩ T cells
Specific CD8 ϩ T cell functions have been ascribed to distinct populations defined by immunophenotyping, including expression of the homing receptor CCR7, and different isoforms of CD45R (reviewed in Ref. 43) . Representative plots of the phenotype of the HIV-specific IL-10, CD107a/b-and IFN-␥-positive CD8 ϩ T cells 
FIGURE 2.
Higher Gag-specific IL-10-positive CD8 ϩ T cell frequency is observed in volunteers with a CD4 T cell count Ͻ200 cell/mm 3 . PBMC were stimulated with Gag peptides, then stained with either IL-10 PE, or anti-CD107a/b FITC, IFN-␥ FITC, and anti-CD3 PerCP CY5.5, anti-CD8 allophycocyanin CY7, and anti-CD4 Pacific Blue. Samples were first gated on the CD3 ϩ /CD8 ϩ lymphocyte population then the percentage of IL-10-positive cells was determined. Results were expressed as the percentage of Gag-specific CD8 ϩ T cells expressing IL-10. Bars represent median values. Dashed line represents the cutoff for significant IL-10 expression. Frequencies of Gag-specific IL-10-positive cells were compared in volunteers with CD4 T cell counts Ͻ200 (n ϭ 31) and Ͼ200 (n ϭ 30). Differences in IL-10 expression between the two groups were statistically significant (p ϭ 0.0004). are shown in Fig. 6A . IL-10-positive CD8 ϩ T cells demonstrated a heterogeneous phenotype expression of CCR7, and were mainly CD45 RA-negative (Fig. 6B) . Differences in the pattern of CCR7, but not in CD45 RA, expression between the IL-10 and CD107a/ b-positive Gag-specific CD8 ϩ T cells were statistically significant ( p Ͻ 0.0001 and p ϭ 0.13, respectively). Similar phenotypic differences were also observed between the IL-10-and IFN-␥-positive Gag-specific CD8 ϩ T cells ( p Ͻ 0.0001 and p ϭ 0.42, respectively).
Representative plots of mutually exclusive expression of Gagspecific IL-10-, CD107a/b-, and IFN-␥-positive CD8 ϩ T cells from two volunteers are shown in Fig. 1 . IL-10-positive, but not CD107a/b and IFN-␥-positive, cells were detected in the volunteer with a CD4 T cell count Ͻ200 cells/mm 3 . In contrast, only CD107a/b-and IFN-␥-positive cells were detected in the volunteer with a CD4 T cell count Ͼ200 cells/mm 3 . These results suggest that the Gag-specific IL-10-positive CD8
ϩ T cell population may be distinct from the effector CD8
ϩ T cell populations, as determined by CD107a/b and IFN-␥ expression, and display a heterogenous pattern of CCR7 expression.
Effect of rIL-10 on CD107a/b, and IFN-␥ expression by the Gag-specific CD8
ϩ T cells IL-10 has been shown to modulate CD8 ϩ T cell responses in vitro (14 -17) . Next, we examined the effect of IL-10 on the HIV-specific effector function in vitro. PBMC (n ϭ 10) were stimulated with Gag peptides in the presence of 1 ng/ml rIL-10, and the fre- 
Discussion
HIV infection is associated with increased IL-10 production by PBMC, constitutively, and after mitogen stimulation (44 -47) . Disease progression has been attributed to complex changes in cytokine expression (19, 45, 48 -50) , including a Th1 to Th2 cytokine phenotype switch (46, 47, 51, 52) . However, the role of increased HIV-specific IL-10 expression by CD8 ϩ T cells in modulating T cell dysfunction in chronic HIV infection has not previously been addressed. In this study, the frequency of the HIVspecific IL-10-positive CD8 ϩ T cells was significantly higher in volunteers with AIDS (CD4 T cell count Ͻ200 mm 3 ), and increased IL-10 expression by HIV-specific CD8 ϩ T cells may represent a marker for T cell dysfunction and disease progression.
HIV-specific IL-10-positive CD8 ϩ T cells were positively correlated with plasma HIV RNA. This correlation remained significant after controlling for CD4 T cell count in a multivariate regression analysis. In addition, a complete virologic suppression following ARV therapy was associated with a significant reduction in HIV-1-specific IL-10-positive CD8 ϩ T cells. These results suggest that the generation of HIV-1-specific IL-10-positive CD8 ϩ T cells may be Ag-dependent. Chronic antigenic stimulation in vivo has been shown to result in the generation of IL-10-producing CD4 ϩ T cells that have regulatory properties (53) . We postulate that chronic HIV antigenic stimulation may also drive the activation and expansion of Ag-driven IL-10-producing regulatory CD8 ϩ T cells. Alternatively, the presence of IL-10-positive CD8 ϩ T cells may simply reflect on the state of immune dysfunction associated with increased plasma HIV RNA. Decreased IL-10 on ARV therapy may therefore indicate an improved immune functional state as a result of immune reconstitution.
The presence of HIV-specific IL-10-positive CD8 ϩ T cells was associated with significantly reduced HIV-1-specific cytolysis in our study. This finding leads us to postulate that HIV-specific IL-10-positive CD8 ϩ T cells may exert an inhibitory effect on distinct populations of HIV-specific effector CD8 ϩ T cells. However, a similar association between HIV-specific IL-10-positive cells and HCMV-specific cytolysis was not observed, and may reflect on distinct differences in viral immunopathogenesis. Whether the effect of HIV-specific IL-10-positive cells is Ag specific and if they are associated with altered responses against other non-HIV recall Ags remains to be determined.
Analysis of the surface memory marker expression of the IL-10-positive Gag-specific CD8 ϩ T cells demonstrated a significant difference in the pattern of memory marker expression compared with other effector CD8 ϩ T cells. However, the IL-10-positive CD8 ϩ T cells displayed a heterogenous pattern of surface immunophenotypes and perhaps a better identification of this T cell population will require functional characterization such as IL-10 production.
Distinct T cell populations with regulatory functions produce IL-10 (54 -57). CD25 ϩ CD4 ϩ regulatory T cells (58 -63) are able to inhibit immune responses both in vitro and in vivo (58, 64 -66) . Suppression seems to be mediated by cell contact-dependent mechanisms (58, (67) (68) (69) and cytokines such as IL-10 (60, 61, 70). More recently, CD8
ϩ T cells with regulatory properties have also been described (71) (72) (73) (74) (75) . However, the role of IL-10-producing CD8 ϩ T cells in modulating HIV-specific T cell responses has not been previously addressed. Whether Gag-specific IL-10-positive CD8 ϩ T cells display similar suppressive properties described in other IL-10-producing regulatory T cells remains to be determined. Previous studies have found that proliferation of CD4 ϩ T cells from HIV-infected individuals was inversely associated with the levels of IL-10, and that responses were partially restored by anti-IL-10 Abs (76, 77) . In this study, the addition of rIL-10 suppressed in vitro expression of HIV-specific CD107a/b. These results suggest that IL-10 and IL-10-positive CD8 ϩ T cells may exert a direct inhibitory effect on cytolytic function in vitro. The function of the IL-10-positive CD8 ϩ T cells in vivo remains unknown, and direct cell-cell contact may also be required for the IL-10-positive CD8 ϩ T cells exert their maximum inhibitory effect. In summary, our study demonstrates the presence of an HIV-specific IL-10-positive CD8
ϩ T cell population in advanced disease that may have regulatory properties. These findings warrant further investigation of the respective contribution of these IL-10-positive CD8 ϩ T cells to HIV immunopathogenesis and disease progression.
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